Myrtelle Announces Presentation of Positive 12-month Post Treatment Data in its First-in-Human Clinical Study of rAAV-Olig001-ASPA Gene Therapy at the 2023 Cell & Gene Meeting on the Mesa held by the Alliance for Regenerative Medicine
Wakefield, Mass., October 10, 2023 – Myrtelle Inc. (“Myrtelle” or the “Company”), a gene therapy company focused on developing transformative treatments for neurodegenerative diseases…
Article Date
October 10, 2023
This article is featured on another website.
Go to article
June 1, 2026
HiRO to Attend BIO International Convention 2026 in San Diego
HiRO Is Heading to BIO International Convention 2026 in San Diego, find us a booth…
June 1, 2026
HiRO to Attend BIO International Convention 2026 in San Diego
HiRO Is Heading to BIO International Convention 2026 in San Diego, find us a booth…
June 1, 2026
Chime Biologics and Daewoong Pharmaceutical Enter Strategic Partnership to Advance Dupilumab Biosimilar Development and Commercialization in Global Markets
June 1, 2026